These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Reduction of lipopolysaccharide-induced interleukin-6 production by the kappa opioid U50,488 in a mouse monocyte-like cell line. Parkhill AL; Bidlack JM Int Immunopharmacol; 2006 Jun; 6(6):1013-9. PubMed ID: 16644488 [TBL] [Abstract][Full Text] [Related]
10. Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway. Yu XC; Wang HX; Pei JM; Wong TM J Mol Cell Cardiol; 1999 Oct; 31(10):1809-19. PubMed ID: 10525419 [TBL] [Abstract][Full Text] [Related]
11. Sciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by kappa opioid activation of p38 mitogen-activated protein kinase. Xu M; Bruchas MR; Ippolito DL; Gendron L; Chavkin C J Neurosci; 2007 Mar; 27(10):2570-81. PubMed ID: 17344394 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of interleukin-1 and tumor necrosis factor-alpha synthesis following treatment of macrophages with the kappa opioid agonist U50, 488H. Belkowski SM; Alicea C; Eisenstein TK; Adler MW; Rogers TJ J Pharmacol Exp Ther; 1995 Jun; 273(3):1491-6. PubMed ID: 7791124 [TBL] [Abstract][Full Text] [Related]
13. Kappa-opioid receptors on lymphocytes of a human lymphocytic cell line: morphine-induced up-regulation as evidenced by competitive RT-PCR and indirect immunofluorescence. Suzuki S; Chuang LF; Doi RH; Bidlack JM; Chuang RY Int Immunopharmacol; 2001 Sep; 1(9-10):1733-42. PubMed ID: 11562065 [TBL] [Abstract][Full Text] [Related]
14. Quantification of kappa opioid receptor ligand potency, efficacy and desensitization using a real-time membrane potential assay. Zhao Y; Joshi AA; Aldrich JV; Murray TF Biomed Pharmacother; 2021 Nov; 143():112173. PubMed ID: 34536757 [TBL] [Abstract][Full Text] [Related]
16. The Protective Effects of Κ-Opioid Receptor Stimulation in Hypoxic Pulmonary Hypertension Involve Inhibition of Autophagy Through the AMPK-MTOR Pathway. Zhou Y; Wang Y; Wang X; Tian X; Zhang S; Yang F; Guo H; Fan R; Feng N; Jia M; Gu X; Wang Y; Li J; Pei J Cell Physiol Biochem; 2017; 44(5):1965-1979. PubMed ID: 29224002 [TBL] [Abstract][Full Text] [Related]
17. Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeys. Negus SS Psychopharmacology (Berl); 2004 Nov; 176(2):204-13. PubMed ID: 15112031 [TBL] [Abstract][Full Text] [Related]
18. The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat. Tejeda HA; Chefer VI; Zapata A; Shippenberg TS Psychopharmacology (Berl); 2010 Jun; 210(2):231-40. PubMed ID: 20232058 [TBL] [Abstract][Full Text] [Related]
19. kappa-Opioid receptor stimulation inhibits augmentation of Ca(2+) transient and hypertrophy induced by isoprenaline in neonatal rat ventricular myocytes - Role of CaMKIIdelta(B). Wu G; Wang H; Yang J; Yang Y; Liu C; Jing L; Wong TM Eur J Pharmacol; 2008 Oct; 595(1-3):52-7. PubMed ID: 18721804 [TBL] [Abstract][Full Text] [Related]
20. Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes. Bruchas MR; Macey TA; Lowe JD; Chavkin C J Biol Chem; 2006 Jun; 281(26):18081-9. PubMed ID: 16648139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]